Poseidon Nickel Limited (POS) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
23 Oct 2024 9:37AM |
$0.006 |
$0.006 |
fallen by
8.33%
|
|
POS - Price-sensitive ASX Announcement
Full Release
Key Points
- Poseidon Nickel Limited requested a trading halt on 23 October 2024.
- The halt is pending an announcement about a potential change of control transaction.
- The trading halt will remain until the announcement is made or until normal trading resumes on 25 October 2024.
- The request complies with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Centaurus Metals Limited (CTM) ORDINARY FULLY PAID |
Materials |
$174 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Oct 2024 9:37AM |
$0.490 |
$0.350 |
fallen by
28.57%
|
|
CTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Jaguar Mineral Resource increased to 1.2Mt of contained nickel.
- Updated Mineral Resource Estimate underpins ongoing optimization work.
- Feasibility study forecasts production averaging 18,700tpa of nickel.
- Low capital intensity with pre-production CAPEX of US$371 million.
- First quartile C1 cash cost of US2.30/lb and AISC of US$3.57/lb.
- Post Tax operating cash flow of US$2.11 billion and Post Tax NPV8 of A$997 million.
- Maiden drill program at Bo Novo identified high-grade copper-gold mineralization.
- Quarterly cash reserves reported at significant levels to support ongoing projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$10 |
Percheron to launch Share Purchase Plan
|
23 Oct 2024 9:36AM |
$0.084 |
$0.009 |
fallen by
89.29%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- Percheron Therapeutics Limited will undertake a Share Purchase Plan (SPP) for existing shareholders.
- The SPP offers shares at A$0.08, a 14% discount to the recent trading price.
- The maximum amount the SPP aims to raise is A$2 million.
- Eligible shareholders are those with addresses in Australia and New Zealand as of 22 October 2024.
- Applications for the SPP are capped at A$30,000 per shareholder.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Suvo Strategic Minerals Limited (SUV) ORDINARY FULLY PAID |
Materials |
- |
Proposed issue of securities - SUV
|
23 Oct 2024 9:36AM |
$0.054 |
$0.031 |
fallen by
42.59%
|
|
Suvo Strategic Minerals Limited (SUV) ORDINARY FULLY PAID |
Materials |
- |
Capital Raising Presentation
|
23 Oct 2024 9:36AM |
$0.054 |
$0.031 |
fallen by
42.59%
|
|
Suvo Strategic Minerals Limited (SUV) ORDINARY FULLY PAID |
Materials |
- |
PERMAcast Cornerstone $2M Placement
|
23 Oct 2024 9:35AM |
$0.054 |
$0.031 |
fallen by
42.59%
|
|
SUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Firm commitments for A$2.0 million received under an oversubscribed Placement.
- The shareholders of PERMAcast will take up 15% of the total Placement.
- Funds will support the development and commercialization of low carbon cement IP.
- The placement will issue 41,666,666 shares at $0.048 each.
- Discounts were applied to the share price based on recent trading averages.
- The funds will help advance opportunities with PT Huadi for geopolymer cement.
- Suvo has successfully produced new geopolymer concrete formulations with reduced emissions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Kairos Minerals Limited (KAI) ORDINARY FULLY PAID |
Materials |
$82 |
Notice of Annual General Meeting/Proxy Form
|
23 Oct 2024 9:35AM |
$0.018 |
$0.031 |
risen by
72.22%
|
|
Aldoro Resources Ltd (ARN) ORDINARY FULLY PAID |
Materials |
$59 |
Acquisition of two diamond drill rigs
|
23 Oct 2024 9:35AM |
$0.077 |
$0.320 |
risen by
315.58%
|
|
Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,600 |
AGM addresses and presentation
|
23 Oct 2024 9:34AM |
$0.465 |
$0.700 |
risen by
50.54%
|
|
Zeotech Limited (ZEO) ORDINARY FULLY PAID |
Materials |
$129 |
Japanese Patent Granted for Zeolite Production Technology
|
23 Oct 2024 9:34AM |
$0.030 |
$0.069 |
risen by
130%
|
|
ZEO - Price-sensitive ASX Announcement
Full Release
Key Points
- Zeotech Limited secured a Japanese patent for impurity-free zeolite processing technology.
- The patent is a significant milestone for the company entering the Japanese market.
- Japan's zeolite market is valued at approximately AU$240 million per year.
- The technology was developed during a Pilot Program with the University of Queensland.
- Zeotech aims to pursue patent protection in multiple countries to expand its commercial opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$712 |
ABA: Scheme Booklet registered with ASIC
|
23 Oct 2024 9:33AM |
$3.750 |
$4.210 |
risen by
12.27%
|
|
MYS - Price-sensitive ASX Announcement
Full Release
Key Points
- MyState Bank Limited proposes to acquire 100% of Auswide Bank Limited shares.
- The Scheme Booklet has been registered with ASIC and includes an independent expert's report.
- The Auswide Board unanimously recommends shareholders vote in favor of the acquisition.
- The Scheme Meeting is scheduled for December 2, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Auswide Bank Ltd (ABA) ORDINARY FULLY PAID |
Financials |
- |
Scheme Booklet registered with ASIC
|
23 Oct 2024 9:33AM |
$4.070 |
$5.110 |
risen by
25.55%
|
|
ABA - Price-sensitive ASX Announcement
Full Release
Key Points
- Scheme Booklet registered with ASIC
- MyState Bank Limited proposes to acquire Auswide Bank Ltd
- Scheme Meeting scheduled for 2 December 2024
- Auswide shareholders to vote on the Scheme
- Independent Expert's report concludes the Scheme is in shareholders' best interests
- If approved, Auswide will be a wholly owned subsidiary of MyState Bank
- Auswide shares will be delisted from ASX post-acquisition
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
New Age Exploration Limited (NAE) ORDINARY FULLY PAID |
Energy |
$8 |
Proposed issue of securities - NAE
|
23 Oct 2024 9:32AM |
$0.006 |
$0.003 |
fallen by
50%
|
|
Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$48 |
FY24 AGM and Q1 FY25 Investor Briefing Invitation
|
23 Oct 2024 9:32AM |
$0.024 |
$0.041 |
risen by
70.83%
|
|
AGL Energy Limited (AGL) ORDINARY FULLY PAID |
Utilities |
$6,586 |
Notification regarding unquoted securities - AGL
|
23 Oct 2024 9:31AM |
$11.590 |
$9.790 |
fallen by
15.53%
|
|
Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$2,688 |
Annual Report
|
23 Oct 2024 9:31AM |
$3.290 |
$2.850 |
fallen by
13.37%
|
|
New Age Exploration Limited (NAE) ORDINARY FULLY PAID |
Energy |
$8 |
NAE raises $1.75m to further exploration activities
|
23 Oct 2024 9:30AM |
$0.006 |
$0.003 |
fallen by
50%
|
|
NAE - Price-sensitive ASX Announcement
Full Release
Key Points
- NAE raises $1,750,000 to advance its exploration activities.
- Funding will support ongoing work at Wagyu Gold Project and Lammerlaw Gold and Antimony Project.
- RC drilling will commence on high-priority targets at Wagyu Gold Project.
- Phase 1 and 2 drilling at Wagyu has shown promising results.
- Nine high-priority drill targets defined at Lammerlaw based on recent surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$502 |
Company Secretary Appointment/Resignation
|
23 Oct 2024 9:30AM |
$0.063 |
$0.105 |
risen by
66.67%
|
|
Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$6 |
Successful Completion of Public Shortfall Offer
|
23 Oct 2024 9:29AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
PRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of the public shortfall offer by Prodigy Gold NL.
- Raised approximately $1,677,532 from firm bids for the remaining shortfall.
- Total capital raised under the rights issue now stands at approximately $2,106,894.
- Shortfall placement involved issuing new shares at an issue price of $0.002.
- Ignite Equity Pty Ltd engaged as the lead manager for the shortfall placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$108 |
Quarterly Appendix 5B Cash Flow Report
|
23 Oct 2024 9:29AM |
$0.066 |
$0.066 |
fallen by
0%
|
|
PTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow of $4.2 million from operating activities.
- Positive cash inflow of $3.4 million from investing activities.
- Cash and cash equivalents at quarter end were $66.7 million.
- Significant exploration and evaluation costs impacted operating cash flow.
- Staff and administrative expenses contributed to the cash outflow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$16 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Oct 2024 9:28AM |
$0.050 |
$0.015 |
fallen by
70%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech announced important clinical updates for the NTIASD2 Phase II/III trial for ASD.
- The trial met primary and all key secondary endpoints with statistically significant improvements.
- NTI164 showed significant treatment effects on anxiety, depression, and mood in ASD patients.
- Neurotech received HREC approval for a Phase I/II trial for Spastic Diplegia Cerebral Palsy.
- The company commenced animal pharmacology and toxicology studies for FDA IND-enabling.
- Neurotech closed the quarter with cash and cash equivalents totaling $8.7 million.
- The company aims to secure orphan drug designations for NTI164 in Rett Syndrome.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Venus Metals Corporation Limited (VMC) ORDINARY FULLY PAID |
Materials |
$20 |
Notice of Annual General Meeting/Proxy Form
|
23 Oct 2024 9:28AM |
$0.050 |
$0.100 |
risen by
100%
|
|
Unico Silver Limited (USL) ORDINARY FULLY PAID |
Materials |
$120 |
Sale of Cobar Tenements
|
23 Oct 2024 9:27AM |
$0.325 |
$0.275 |
fallen by
15.38%
|
|
Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Proposed issue of securities - NGS
|
23 Oct 2024 9:26AM |
$0.036 |
$0.023 |
fallen by
36.11%
|
|
TZ Limited (TZL) ORDINARY FULLY PAID |
Information Technology |
$15 |
Notice of Annual General Meeting & Proxy Form
|
23 Oct 2024 9:26AM |
$0.070 |
$0.052 |
fallen by
25.71%
|
|